<?xml version='1.0' encoding='utf-8'?>
<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" version="3.7" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
  <titleInfo>
    <title>THERMO-RESPONSIVE HYDROGELS FOR INTRAVITREAL INJECTION AND BIOMOLECULE RELEASE</title>
  </titleInfo>
  <name>
    <role>
      <roleTerm type="text" authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/cre">creator</roleTerm>
    </role>
    <namePart>Drapala, Pawel</namePart>
  </name>
  <name authority="wikidata" authorityURI="https://www.wikidata.org" valueURI="https://www.wikidata.org/wiki/Q132158772">
    <role>
      <roleTerm type="text" authority="marcrelator" authorityURI="http://id.loc.gov/vocabulary/relators" valueURI="http://id.loc.gov/vocabulary/relators/ths">advisor</roleTerm>
    </role>
    <namePart>Perez-Luna, Victor H.</namePart>
  </name>
  <abstract>In this dissertation, we develop an injectable polymer system to enable localized and prolonged release of therapeutic biomolecules for improved treatment of Age-Related Macular Degeneration (AMD). Thermo-responsive hydrogels derived from N-isopropylacrylamide (NIPAAm) and cross-linked with poly(ethylene glycol) (PEG) poly(L-Lactic acid) (PLLA) copolymer were synthesized via free-radical polymerization. These materials were investigated for (a) phase change behavior, (b) in-vitro degradation, (c) capacity for controlled drug delivery, and (d) biocompatibility. The volume-phase transition temperature (VPTT) of the PNIPAAm-co-PEG- b-PLLA hydrogels was adjusted using hydrophilic and hydrophobic moieties so that it is ca. 33 C. These hydrogels did not initially show evidence of degradation at 37 C due to physical cross-links of collapsed PNIPAAm. Only after addition of glutathione chain transfer agents (CTA)s to the precursor did the collapsed hydrogels become fully soluble at at 37 C. CTAs signi cantly a ected the release kinetics of biomolecules; addition of 1.0 mg/mL glutathione to 3 mM cross-linker accelerated hydrogel degradation, resulting in 100 % release in less than 2 days. This work also explored the e ect of PEGylation in order to tether biomolecules to the polymer matrix. It was demonstrated that non-site-speci c PEGylation can postpone the burst release of solutes (up to 10 days in hydrogels with 0.5 mg/mL glutathione). Cell viability assays showed that at least two 20-minute bu er extraction steps were needed to remove cytotoxic elements from the hydrogels. Clinically-used therapeutic biomolecules Lucentis® and Avastin® were demonstrated to be both stable and bioactive after release form PNIPAAm-co-PEG-b-PLLA hydrogels. The thermo-responsive hydrogels presented here o er a promising platform for the localized delivery of proteins such as recombinant antibodies.</abstract>
  <note type="provenance">Submitted by Dana Lamparello (dlampare@iit.edu) on 2012-02-28T17:28:41Z No. of bitstreams: 1 110420 pd thesis final.pdf: 2674881 bytes, checksum: 083a8382fd653f2306155cdb4dd78f57 (MD5)</note>
  <note type="provenance">Made available in DSpace on 2012-02-28T17:28:41Z (GMT). No. of bitstreams: 1 110420 pd thesis final.pdf: 2674881 bytes, checksum: 083a8382fd653f2306155cdb4dd78f57 (MD5) Previous issue date: 2011-05</note>
  <note type="thesis">Ph.D. in Chemical and Biological Engineering, May 2011</note>
  <originInfo>
    <dateCaptured>2011-04-20</dateCaptured>
  </originInfo>
  <originInfo>
    <dateCreated keyDate="yes">2011-05</dateCreated>
  </originInfo>
  <identifier type="hdl">http://hdl.handle.net/10560/2500</identifier>
  <language>
    <languageTerm type="code" authority="rfc3066">en</languageTerm>
  </language>
  <typeOfResource authority="aat" valueURI="http://vocab.getty.edu/page/aat/300028029">Dissertation</typeOfResource>
  <physicalDescription>
    <digitalOrigin>born digital</digitalOrigin>
    <internetMediaType>application/pdf</internetMediaType>
  </physicalDescription>
  <accessCondition type="useAndReproduction" displayLabel="rightsstatements.org">In Copyright</accessCondition>
  <accessCondition type="useAndReproduction" displayLabel="rightsstatements.orgURI">http://rightsstatements.org/page/InC/1.0/</accessCondition>
  <accessCondition type="restrictionOnAccess">Restricted Access</accessCondition>
  <name type="corporate">
    <namePart>ChBE / Chemical and Biological Engineering</namePart>
    <affiliation>Illinois Institute of Technology</affiliation>
    <role>
      <roleTerm type="text">Affiliated department</roleTerm>
    </role>
  </name>
</mods>